Position in NXTC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$273,923
-$372,580 QoQ
Shares Held
171,202
+182.8% QoQ
Ownership
3.74%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 30 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NXTC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. NXTC ranks #238 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in NXTC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $273,923 | 171,202 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $646,503 | 60,534 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $477,266 | 33,634 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $166,037 | 28,334 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $230,430 | 500,935 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $230,381 | 479,962 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $400,380 | 519,300 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $556,219 | 406,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $734,808 | 462,144 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $892,891 | 400,400 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $334,379 | 293,315 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $322,757 | 250,200 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $444,959 | 247,200 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $361,859 | 244,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $573,284 | 406,585 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $632,499 | 230,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,371,196 | 291,744 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $723,167 | 148,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $657,599 | 109,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,521,433 | 374,100 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,608,408 | 200,300 | Shares | Sole | 2021-08-13 | |
| 2020-06-30 | $1,374,303 | 64,100 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||